CausalSentinel

Protein Dossier — NPPB (Natriuretic peptides B)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Neuroblastoma 0.216 0.162 0.185 Wald ratio 1 cis NA
Thyroid cancer -0.355 0.317 0.263 Wald ratio 1 cis NA
Childhood intelligence 0.05 0.0591 0.398 Wald ratio 1 trans NA
Knee osteoarthritis 0.0878 0.124 0.479 Wald ratio 1 trans NA

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3723_1_2 BNP-32 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

83 association rows across 49 traits (78 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating NTproBNP levels (id: OID01214_OID20125) 7e-506 rs198389 2 GCST90860419 no MR -> candidate analysis
Circulating NTproBNP levels (id: OID00455_OID20125) 2e-468 rs198389 2 GCST90859816 no MR -> candidate analysis
Circulating NTproBNP levels (id: OID00131_OID20125) 4e-409 rs198389 2 GCST90859652 no MR -> candidate analysis
Circulating NPPB levels (id: OID01214_OID20049) 3e-292 rs198389 1 GCST90860418 no MR -> candidate analysis
Circulating NPPB levels (id: OID00455_OID20049) 7e-260 rs198389 1 GCST90859815 no MR -> candidate analysis
Circulating NPPB levels (id: OID00131_OID20049) 3e-200 rs198389 1 GCST90859651 no MR -> candidate analysis
NPPB protein levels 5e-174 rs198389 1 GCST90470074 no MR -> candidate analysis
B-type natriuretic peptide to N-terminal pro B-type natriure 5e-103 rs61761991 1 GCST005208 no MR -> candidate analysis
NTPROBNP protein levels 1e-84 rs5229 2 GCST90470096 no MR -> candidate analysis
N-terminal pro-BNP levels 9e-80 rs198379 4 GCST90248745 no MR -> candidate analysis
N-terminal prohormone brain natriuretic peptide levels 3e-77 rs198389 2 GCST90012082 no MR -> candidate analysis
N-terminal pro B-type natriuretic peptide levels 9e-68 rs61761991 2 GCST005205 no MR -> candidate analysis
…and 37 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1371 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hypertensive disorder 0.76 common-variant locus no MR -> candidate analysis
Increased blood pressure 0.634 common-variant locus no MR -> candidate analysis
major depressive disorder 0.294 common-variant locus no MR -> candidate analysis
alcohol drinking 0.307 common-variant locus no MR -> candidate analysis
viral eye infection 0.302 common-variant locus no MR -> candidate analysis
spinal cord injury 0.3 common-variant locus no MR -> candidate analysis
ankylosing spondylitis 0.289 common-variant locus no MR -> candidate analysis

Of the 7 rows above, 7 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=2.1e-05, LOEUF=1.63 — LoF-tolerant
GWAS Catalog 241 unique SNPs / 580 rows
ClinVar 84 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance